¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"product line management"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • continuous cell line
    ¹«ÇÑÁõ½Ä¼¼Æ÷ÁÖ, ¿¬¼Ó°è´ë¼¼Æ÷ÁÖ
  • cell line
    ¼¼Æ÷ÁÖ, ¼¼Æ÷°è
  • cement line
    ½Ã¸àÆ®¼±, °áÇÕ¼±
  • dynamic skin line
    µ¿ÀûÇǺμ±
  • developmental line
    ¹ß´Þ¼±, ¹ßÀ°À¶ÇÕ¼±
  • diploid cell line
    µÎ¹è¼öü¼¼Æ÷°è, À̹èü¼¼Æ÷°è
  • embryonic line
    ¹è¾Æ¼±
  • epiphyseal line
    »À³¡¼±, °ñ´Ü¼±
  • established cell line
    È®¸³¼¼Æ÷ÁÖ
  • fixation line
    Áֽü±
  • germ line
    Á¾ÀÚ°è
  • gingival line
    ÀÕ¸ö¼±, Ä¡Àº¼±
  • gluteal line
    º¼±â±Ù¼±, µÐ±Ù¼±
  • gravitational skin line
    Áß·ÂÇǺμ±
  • growth arrest line
    ¼ºÀåÁ¤Áö¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • base line
    ¹ÙÅÁ¼±, ±âÁؼ±
  • base line shift
    ±âÁؼ±À̵¿
  • blood line
    Ç÷Á·°è
  • blue line
    (¢¡lead line) ³³¼±
  • cell line
    ¼¼Æ÷°è, ¼¼Æ÷ÁÖ
  • cement line
    °áÇÕ¼±
  • cleavage line
    ºÐÇÒ¼±
  • continuous cell line
    ¹«ÇÑÁõ½Ä¼º¼¼Æ÷ÁÖ, ¿¬¼Ó°è´ë¼¼Æ÷ÁÖ
  • developmental line
    ¹ß´Þ¼±, ¹ßÀ°À¶ÇÕ¼±
  • diploid cell line
    À̹èü¼¼Æ÷°è
  • double line hemorrhage
    µÎÁÙÃâÇ÷
  • dynamic skin line
    µ¿ÀûÇǺμ±
  • embryonic line
    ¹è¾Æ¼±
  • epiphyseal line
    »À³¡¼±, °ñ´Ü¼±
  • established cell line
    È®¸³¼¼Æ÷ÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Staehlis line
    ½ºÅÚ¸®¼±
  • Stocker line
    ½ºÅåÄ¿¼±
  • Vogts line
    º¸Å©Æ®¼±
  • Voigt line
    Æ÷ÀÌÆ®¼±
  • Z line(=disc)
    Z¼± (ÆÇ)
  • absorption line
    Èí¼ö¼±.
  • alveolar hard line
    Ä¡Á¶°æ¼±(öÍðËÌãàÊ).
  • alveolar ridge line
    Ä¡Á¶Á¤¼±(¡­ð¢àÊ).
  • anocutaneal line
    Ç×¹®ÇǺμ±
  • anocutaneous line
    Ç×¹®ÇǺμ±
  • anorectal line
    Ç×¹®°ðâÀÚ¼±
  • anterior axillary line
    ¾Õ°Üµå¶û¼±
  • anterior gluteal line
    ¾Õº¼±â±Ù¼±
  • arcuate line
    Ȱ²Ã¼±
  • germ line
    ¹è¼±(ÛÏàÊ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ionic product
    ÀÌ¿ÂÀû(¡­îÝ), À̿»깰.
  • metabolic product
    ´ë»ç»ê¹°(¡­ß§Úª).
  • otoacoustic emission, distortion product
    ÀÌÀ½Çâ¹æ»ç¿Ö°î¹°
  • product costing
    Á¦Ç°°¡°Ý»êÁ¤
  • product of metabolism
    ´ë»ç»ê¹°(ÓÛÞóß§Úª).
  • skin care product
    ÇǺΰü¸®Á¦
  • split product
    ºÐ¸®»ê¹°.
  • substitution product
    ġȯü(öÇüµô÷).
  • tensile product
    ½ÅÀåÀû(ãßíåîÝ).
  • absorption line
    Èí¼ö¼±.
  • alveolar hard line
    Ä¡Á¶°æ¼±(öÍðËÌãàÊ).
  • alveolar ridge line
    Ä¡Á¶Á¤¼±(¡­ð¢àÊ).
  • anocutaneal line
    Ç×¹®ÇǺμ±
  • anocutaneous line
    Ç×¹®ÇǺμ±
  • anorectal line
    Ç×¹®°ðâÀÚ¼±
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Superior nuchal line
    À§¸ñ´ú¹Ì¼±
    [¿¾ ¿ë¾î] »óÇ×(¸ñ´ú¹Ì)¼±
  • Intercondylar line
    À¶±â»çÀ̼±
    [¿¾ ¿ë¾î] °ú°£¼±
  • Mammary line
    Á¥²ÀÁö¼±
    [¿¾ ¿ë¾î] À¯µÎ¼±
  • Midaxillary line
    Áß°£°Üµå¶û¼±
    [¿¾ ¿ë¾î] Áß°£¾×¿Í¼±
  • Intermediate line
    Áß°£´É¼±
    [¿¾ ¿ë¾î] Áß°£¼±
  • Neonatal line
    ù¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Å»ý¼±
  • Mylohyoid line
    Åθñ»Ô±Ù¼±
    [¿¾ ¿ë¾î] ¾Ç¼³°ñ±Ù¼±
  • Anorectal line
    Ç×¹®°ðâÀÚ¼±
    [¿¾ ¿ë¾î] Ç×¹®Á÷Àå¼±
  • Anocutaneal line
    Ç×¹®ÇǺμ±
    [¿¾ ¿ë¾î] Ç×¹®ÇǺμ±
  • Anocutaneous line
    Ç×¹®ÇǺμ±
    [¿¾ ¿ë¾î] Ç×¹®ÇǺμ±
  • Arcuate line
    Ȱ²Ã¼±
    [¿¾ ¿ë¾î] ±Ã»ó¼±
  • Cement line
    °áÇÕ¼±
    [¿¾ ¿ë¾î] °áÇÕ¼±
  • Z line
    ³¡»çÀ̸· [Z¼±]
    [¿¾ ¿ë¾î] Z¼±
  • Oblique line
    ºñ½ºµë¼±
    [¿¾ ¿ë¾î] »ç¼±
  • Oblique line
    ºø¼±
    [¿¾ ¿ë¾î] »ç¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RM radical mastectomy; random migration; radon monitor; range of movement; red marrow; reference materi...
FSP Fibrin Split Product
  = FDPs
ADP adenopathy; adenosine diphosphate; administrative psychiatry; approved drug product; area diastolic ...
AGE acrylamide gel; acute gastroenteritis; advanced glycation end product; agarose gel electrophoresis; ...
DAP data acquisition processor; depolarizing afterpotential; diabetes-associated peptide; diaminopimelic...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DPOE Distortion product otoacoustic emissions
DPE Distortion-product otoacoustic emission
DAP Dose area product
ESP Excretory-secretory product
FDP Fibrin Degradation Product
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell line
    ¼¼Æ÷°è
  • cement line
    ½Ã¸àÆ® ¼±
    Ä¡°ü º¸Ã¶¹°À» Áö´ëÄ¡¿¡ Ä¡°ú¿ë ÇÕÂøÁ¦·Î ¿µ±¸ ÇÕÂø½ÃÄ×À» ¶§ ºÎÁ¤È®ÇÑ Á¢ÇÕÀ¸·Î ÇÕÂøÁ¦°¡ ³ëÃâµÇ´Â °Í.
  • cemental line
    ½Ã¸àÆ® ¼±
    °ñÀÇ È¾´Ü¸éÀÇ Çö¹Ì°æ °Ë»ç¿¡¼­ °üÂûµÇ´Â ¼±. °ñ´ÜÀ§ÀÇ °æ°è¸¦ ³ªÅ¸³½´Ù.
  • cervical line
    °æ¼±, Ä¡°æ¼±
    Ä¡±Ù°ú Ä¡°üÀÇ °æ°è¸¦ Ä¡°æ¼±À̶óÇÏ°í ¹ý¶û, ¹é¾ÇÁú °æ°è ºÎÀ§¸¦ ¶æÇϸç neck lineÀ̶ó°íµµ ÇÑ´Ù. ÀÌ ¼±Àº ¿µ±¸ ºÒº¯ÀÇ ¼±ÀÌ´Ù.
  • curve of dental cervical line
    Ä¡°æ ¼± ¸¸°î
  • double line hemorrhage
    µÎ ÁÙ ÃâÇ÷, Áß¼± ÃâÇ÷
  • facial line
    ¾È¸é ÁÖ¸§, ¾È¸é±¸
  • fulcrum line
    ÁöÁ¡ ¼±, Áö·¿ ¼±
  • high lip line
    »ó¼ø¼±
    À­ ÀÔ¼úÀÇ À§ÂÊ °æ°è.
  • incremental line
    ¹ßÀ°¼±
    Á¶Á÷ÀÇ °è¼ÓµÇ´Â Ä§ÂøÃþÀ» ³ªÅ¸³»´Â ¼±.
  • inferior gluteal line
    ¾Æ·¡ º¼±â±Ù ¼±
  • inferior temporal line
    ¾Æ·¡ °üÀÚ ¼±
  • interalveolar line
    ¹«Ä¡¾Ç¿¡ À־ÀÇ Ä¡Á¶Á¤°£¼±
    »óÇÏ¾Ç ¹«Ä¡¾Ç Ä¡Á¶Á¤ÀÇ ´ëÀÀºÎ¸¦ ¸Î´Â Á÷¼±À» Ä¡Á¶Á¤°£¼±À̶ó°í ÇÑ´Ù.
  • intercalar line
    Áß°£¼±
  • keratotic line
    °¢Áú¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
management quality circles Participation of employees with management as a labour-management team, in decisions pertaining to the operational activities of the organization or industry.
(12 Dec 1998)
case management A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained.
(12 Dec 1998)
materials management, hospital The management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc.
(12 Dec 1998)
patient care management Generating, planning, organizing, and administering medical and nursing care and services for patients.
(12 Dec 1998)
personnel management Planning, organizing, and administering all activities related to personnel.
(12 Dec 1998)
risk management The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimised. Effective risk management has its greatest benefits in application to insurance in order to avert or minimise financial liability.
(12 Dec 1998)
waste management Disposal, processing, controlling, recycling, and reusing the solid, liquid, and gaseous wastes of plants, animals, humans, and other organisms. It includes control within a closed ecological system to maintain a habitable environment.
(12 Dec 1998)
safety management The development of systems to prevent accidents, injuries, and other adverse occurrences in an institutional setting. The concept includes prevention or reduction of adverse events or incidents involving employees, patients, or facilities. Examples include plans to reduce injuries from falls or plans for fire safety to promote a safe institutional environment.
(12 Dec 1998)
database management systems Software designed to store, manipulate, manage, and control data for specific uses.
(12 Dec 1998)
decision support systems, management Computer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions.
(12 Dec 1998)
disease management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease.
(12 Dec 1998)
information management Management of the acquisition, organization, storage, retrieval, and dissemination of information.
(12 Dec 1998)
institutional management teams Administrator-selected management groups who are responsible for making decisions pertaining to the provision of integrated direction for various institutional functions.
(12 Dec 1998)
integrated advanced information management systems A concept, developed in 1983 under the aegis of and supported by the national library of medicine under the name of integrated academic information management systems, to provide professionals in academic health sciences centres and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In august 1992 the name was changed from integrated academic information management systems to integrated advanced information management systems to reflect use beyond the academic milieu.
(12 Dec 1998)
intensive management Planned, active treatment to improve the quality and quantity of timber within a stand. A general term that distinguishes active forest management from passive forest management.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • partial product
    ºÎºÐÀû
  • product
    »ý»êǰ;Á¦ÀÛ¹°;°á°ú;¼º°ú;°ö;Àû
  • product concept
    Á¦Ç° °³³ä(²÷ÀÓ¾øÀÌ Á¦Ç°ÀÇ °³¼±À» ²ÒÇÏ´Â °æ¿µ Áöħ)
  • product liability
    (ºÒ·® »óǰ¿¡ ´ëÇØ ¼ÒºñÀÚ¿¡°Ô Áö´Â) »ý»ê¹°(ÀÚ) Ã¥ÀÓ
  • product life cycle
    Á¦Ç°ÀÇ ¶óÀÌÇÁ »çÀÌŬ
  • product mix
    (¸¶ÄÉÆÃ)Á¦Ç° ¹Í½º(ÆÇ¸ÅµÇ´Â ÀüÁ¦Ç°ÀÇ ¸®½ºÆ®,Æø°ú ±íÀÌÀÇ µÎÂ÷¿ø)
  • residual product
    ÀÜ¿© »ý»ê¹°;ºÎ»ê¹°
  • staple product
    ÁÖ¿ä »ê¹°
  • air-line
    °ø·Î¿¡ ÀÇÇÑ
  • bottom line
    °á°ú, ¼øÀÌÀÍ
  • by-line
    À̸§ÀÌ ¾º¾îÀÖ´Â Çà
  • in line with
    -¿Í ÀÏÄ¡ÇÏ¿©
  • line
    ¼±,¿­,³ª¶õÀÌÇÏ´Ù
  • main line
    °£¼±
  • two-line
    ¹èÇüÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á